QHSE Policy
Our policy in Management, Quality, Healthy & Safety, Environment, Economic, certifications which our headquarters HORIBA ABX SAS acquired.
HORIBA's Veterinary Division provides an extensive line of in vitro diagnostic solutions for use in veterinary practice, across PCR, clinical chemistry solutions and individual parameter patient-side testing, including analyzers, reagents and consumables. Sitting with the HORIBA's healthcare business, we are equipped to provide a full service from advice and installation to technical support. Proven quality and trustworthy performance have established widespread confidence in the HORIBA brand. Today, more than 30,000 diagnostic laboratories are using HORIBA’s healthcare solutions around the world.
1,230 employees
5 production centers (Japan, China, France, Brazil, India)
2 R&D centers (Japan, France)
More than 100 distributors
15 local/direct operations
More than 30,000 laboratories supplied worldwide
Globally, our instrumentation has captured a significant portion of the world market with strength in France, Japan, U.K. and America. Distribution is handled through both a direct sales force and all of the major national and regional distributors. Today, present in near 150 countries on all five continents, with internationally recognized instruments and a leader’s ranking in most markets, HORIBA is a world leader on the Hematology market. The strength of its distribution network coupled with its experience allows HORIBA to operate efficiently in international markets.
HORIBA has 1,230 employees engaged in its healthcare solutions across its sites and subsidiaries. In 2022, it produced nealy 7,000 healthcare instruments and over 9,000 tons of reagents. Our direct team of in-house Technical Service Representatives along with nationwide coverage of Field Service Representatives offers un-paralleled remote and on-site service. With the added value of a direct team of Systems Installation Specialists, these med-tech's are a key component to a successful installation and on-going support. HORIBA's healthcare solutions also benefit from technologies patented by the HORIBA Group and the synergies between all its research centers throughout the world. Since ABX S.A. joined the HORIBA Group in 1996, marking the start of HORIBA's healthcare business, our healthcare solutions have grown significantly, reaching sales of 226 MUSD in 2022.
Montpellier instrument production site
Providing reliable, high-quality healthcare devices that are trusted by our customers and meet their expectations: such is the ambition that drives the daily work of our teams, who are fully committed towards developing healthcare solutions for tomorrow. HORIBA has earned an international reputation for its high standards of innovation. The flexibility of its production units and the recognized technological creativity of its R&D centers give it a real edge in the development of evolving products in line with market needs.
Montpellier Innovation and Development Center
Faced with ever more demanding quality standards, HORIBA deploys a rigorous and inventive policy to meet and respond to these by anticipating trends. It is audacious in its technological creativity while always remaining faithful to its commitment to the environment. The company aims to maintain the confidence of its customers and strengthen its position on a global scale.
HORIBA is extremely aware of current sustainable development issues and is committed to reducing the environmental footprint of its activities, notably by promoting the eco-design of its products. For example, this implies designing equipment that is more economical in terms of electricity and reagents; devices that are increasingly compact and light; total dematerialization of patient results; optimization of logistics; development of more eco-responsible reagents.
Sie haben Fragen oder Wünsche? Nutzen Sie dieses Formular, um mit unseren Spezialisten in Kontakt zu treten.
